103 related articles for article (PubMed ID: 15257943)
1. TP53 codon 72 polymorphism in patients with chronic myeloid leukemia.
Bergamaschi G; Merante S; Orlandi E; Galli A; Bernasconi P; Cazzola M
Haematologica; 2004 Jul; 89(7):868-9. PubMed ID: 15257943
[TBL] [Abstract][Full Text] [Related]
2. Lack of association of XRCC1 codon 399Gln polymorphism with chronic myelogenous leukemia.
Deligezer U; Akisik EE; Dalay N
Anticancer Res; 2007; 27(4B):2453-6. PubMed ID: 17695538
[TBL] [Abstract][Full Text] [Related]
3. Arginine homozygosity in codon 72 of p53 correlates with failure to imatinib response in chronic myeloid leukemia.
Camelo-Santos J; do Prado Barbosa A; de Paula Silveira-Lacerda E; Guillo LA
Biomed Pharmacother; 2013 Mar; 67(2):103-7. PubMed ID: 23433851
[TBL] [Abstract][Full Text] [Related]
4. The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas.
Langerød A; Bukholm IR; Bregård A; Lønning PE; Andersen TI; Rognum TO; Meling GI; Lothe RA; Børresen-Dale AL
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1684-8. PubMed ID: 12496062
[TBL] [Abstract][Full Text] [Related]
5. p53 mutation arising in Arg72 allele in the tumorigenesis and development of carcinoma of the urinary tract.
Furihata M; Takeuchi T; Matsumoto M; Kurabayashi A; Ohtsuki Y; Terao N; Kuwahara M; Shuin T
Clin Cancer Res; 2002 May; 8(5):1192-5. PubMed ID: 12006537
[TBL] [Abstract][Full Text] [Related]
6. Frequency of TP53 mutations in relation to Arg72Pro genotypes in non small cell lung cancer.
Lind H; Ekstrøm PO; Ryberg D; Skaug V; Andreassen T; Stangeland L; Haugen A; Zienolddiny S
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2077-81. PubMed ID: 17932356
[TBL] [Abstract][Full Text] [Related]
7. Potential increase in the prognostic value of p53 mutation by Pro72 allele in stage I non-small-cell lung cancer.
Chien WP; Wong RH; Wu TC; Cheng YW; Chen CY; Lee H
Ann Surg Oncol; 2009 Jul; 16(7):1918-24. PubMed ID: 19434453
[TBL] [Abstract][Full Text] [Related]
8. Arginine and proline alleles of the p53 gene are associated with different locations of gastric cancer.
Lai KC; Chen WC; Tsai FJ; Li SY; Jeng LB
Hepatogastroenterology; 2005; 52(63):944-8. PubMed ID: 15966238
[TBL] [Abstract][Full Text] [Related]
9. [TP53 codon 72 polymorphism and gastric cancer risk: a case-control study in individuals from the central-western region of Venezuela].
Cañas M; Morán Y; Camargo ME; Rivero MB; Bohórquez A; Villegas V; Ramírez E; Rendón Y; Suárez A; Morales L; Useche E; Salazar S; Zambrano A; Ramírez A; Valderrama E; Briceño Z; Chiurillo MA
Invest Clin; 2009 Jun; 50(2):153-61. PubMed ID: 19662811
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism.
Szymanowska A; Jassem E; Dziadziuszko R; Borg A; Limon J; Kobierska-Gulida G; Rzyman W; Jassem J
Lung Cancer; 2006 Apr; 52(1):9-14. PubMed ID: 16499995
[TBL] [Abstract][Full Text] [Related]
11. Two germ line polymorphisms of the tumour suppressor gene p53 may influence the biology of chronic lymphocytic leukaemia.
Kochethu G; Delgado J; Pepper C; Starczynski J; Hooper L; Krishnan S; Fegan C; Pratt G
Leuk Res; 2006 Sep; 30(9):1113-8. PubMed ID: 16458962
[TBL] [Abstract][Full Text] [Related]
12. Cytokine gene polymorphism in Iranian patients with chronic myelogenous leukaemia.
Amirzargar AA; Bagheri M; Ghavamzadeh A; Alimoghadam K; Khosravi F; Rezaei N; Moheydin M; Ansaripour B; Moradi B; Nikbin B
Int J Immunogenet; 2005 Jun; 32(3):167-71. PubMed ID: 15932621
[TBL] [Abstract][Full Text] [Related]
13. Expression of programmed cell death proteins in patients with chronic myeloid leukemia.
Strnad M; Brajuskovic G; Strelic N; Todoric-Zivanovic B; Stamatovic D; Tatomirovic Z; Magic Z
J BUON; 2008; 13(3):403-8. PubMed ID: 18979557
[TBL] [Abstract][Full Text] [Related]
14. TP53 codon 72 polymorphism in susceptibility, overall survival, and adjuvant therapy response of gliomas.
Lima-Ramos V; Pacheco-Figueiredo L; Costa S; Pardal F; Silva A; Amorim J; Lopes JM; Reis RM
Cancer Genet Cytogenet; 2008 Jan; 180(1):14-9. PubMed ID: 18068527
[TBL] [Abstract][Full Text] [Related]
15. Imatinib resistance in a novel translocation der(17)t(1;17)(q25;p13) with loss of TP53 but without BCR/ABL kinase domain mutation in chronic myelogenous leukemia.
Yamamoto K; Yakushijin K; Nishikawa S; Minagawa K; Katayama Y; Shimoyama M; Matsui T
Cancer Genet Cytogenet; 2008 May; 183(1):77-81. PubMed ID: 18474303
[TBL] [Abstract][Full Text] [Related]
16. [Recovery of polyclonial hemopoiesis in females with chronic myeloid leukemia with a complete cytogenetic response].
Ermakova TA; Chelysheva EIu; Turkina AG; Sokolova MA; Zakharova AV; Danil'cheva ES; Misiurin AV
Ter Arkh; 2007; 79(8):13-6. PubMed ID: 17926464
[TBL] [Abstract][Full Text] [Related]
17. Germline polymorphism of p53 codon 72 in gynecological cancer.
Ueda M; Terai Y; Kanda K; Kanemura M; Takehara M; Yamaguchi H; Nishiyama K; Yasuda M; Ueki M
Gynecol Oncol; 2006 Jan; 100(1):173-8. PubMed ID: 16168468
[TBL] [Abstract][Full Text] [Related]
18. TP53 codon 72 polymorphism and risk of conjunctival squamous cell carcinoma in Uganda.
Tornesello ML; Waddell KM; Duraturo ML; Biryahwaho B; Downing R; Lucas SB; Giani U; Buonaguro L; Buonaguro FM
Cancer Detect Prev; 2005; 29(6):501-8. PubMed ID: 16289503
[TBL] [Abstract][Full Text] [Related]
19. MTHFR 677CC/1298CC genotypes are highly associated with chronic myelogenous leukemia: a case-control study in Korea.
Moon HW; Kim TY; Oh BR; Min HC; Cho HI; Bang SM; Lee JH; Yoon SS; Lee DS
Leuk Res; 2007 Sep; 31(9):1213-7. PubMed ID: 17156840
[TBL] [Abstract][Full Text] [Related]
20. TP53 mutation, allelism and survival in non-small cell lung cancer.
Nelson HH; Wilkojmen M; Marsit CJ; Kelsey KT
Carcinogenesis; 2005 Oct; 26(10):1770-3. PubMed ID: 15905205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]